The TOP2A gene has previously been identified as amplified and upregulated in a large subset of MPNST patient samples (Skotheim et al., 2003), which could explain the positive effect of TOP2A inhibition in these patients. The gene discussed is TOP2A; the disease is malignant peripheral nerve sheath tumor.